Do LORIS trial eligibility criteria identify a ductal carcinoma in situ (DCIS) patient population at low risk of upgrade to invasive carcinoma?

BACKGROUND: The Surgery versus Active Monitoring for Low-Risk DCIS (LORIS) trial is studying the safety of monitoring core-biopsy diagnosed low-risk ductal carcinoma in situ (DCIS) without excision. We sought to determine the incidence and characteristics of synchronous invasive carcinoma found in L...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ann Surg Oncol
Hoofdauteurs: Pilewskie, Melissa, Stempel, Michelle, Rosenfeld, Hope, Eaton, Anne, Van Zee, Kimberly J., Morrow, Monica
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070657/
https://ncbi.nlm.nih.gov/pubmed/27172775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5268-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items